D.Fill Medium: Navigating Regulatory Status and Market Access for Professionals

D.Fill Medium is a hyaluronic acid dermal filler manufactured by D.Pharm Co., Ltd., based in South Korea. The product's origin is a foundational aspect for understanding its initial regulatory framework and the quality control standards applied during its production.

Manufacturers operating within South Korea adhere to national guidelines established by regulatory bodies, ensuring specific production and safety protocols are met before domestic market entry.

Understanding the certifications held by D.Fill Medium is critical for professional buyers.

• KMFDS (Korea Ministry of Food and Drug Safety): As a product originating from South Korea, D.Fill Medium undergoes assessment and approval by the KMFDS. This domestic certification confirms compliance with South Korean standards for product safety and quality within its home market.
• CE Mark (Conformité Européenne): [VERIFY: D.Fill Medium CE Mark status and specific class, e.g., Class III Medical Device]. For distribution within the European Union (EU) and European Economic Area (EEA), the CE Mark is a mandatory conformity marking. This certification indicates that the product meets the essential health, safety, and environmental protection requirements outlined in relevant EU directives or regulations, allowing its free movement across these territories.
• FDA (U.S. Food and Drug Administration): [VERIFY: D.Fill Medium FDA approval status for the United States market]. The U.S. FDA has distinct and stringent requirements for medical devices and drugs. Obtaining FDA approval or clearance typically involves comprehensive clinical data submission and manufacturing facility inspections, a separate process from KMFDS or CE marking.
• GMP (Good Manufacturing Practices) & ISO Standards: Beyond specific product approvals, D.Pharm Co., Ltd. is expected to adhere to Good Manufacturing Practices (GMP) and international ISO standards. [VERIFY: D.Pharm Co., Ltd. GMP and relevant ISO certifications, e.g., ISO 13485 for medical devices]. These certifications are fundamental for ensuring consistent product quality, controlled processes, and robust quality management systems throughout the entire manufacturing cycle.

The lawful market access for D.Fill Medium extends beyond its country of origin, subject to the specific regulatory frameworks of individual nations. In markets such as the United Kingdom, requirements often align with or derive from EU directives, potentially necessitating a valid CE Mark or equivalent UKCA marking [VERIFY: D.Fill Medium UKCA status].

For regions including the GCC (Gulf Cooperation Council), Latin America (LATAM), and APAC (Asia-Pacific), local health authorities (e.g., SFDA in Saudi Arabia, ANVISA in Brazil, TGA in Australia) dictate product registration and import regulations. Professionals sourcing any Hyaluronic acid dermal filler must consult local guidelines or partner with suppliers who can verify product compliance in their specific jurisdiction. This proactive approach ensures adherence to regional import and distribution laws.

Parallel importing involves sourcing products from one authorized market and importing them into another, often through channels outside the manufacturer's official distribution network. While legal in some regions, this practice can introduce complexities concerning product traceability, cold chain maintenance, and warranty support.

Clinics and distributors are advised to exercise thorough diligence to ensure the authenticity and proper handling of all sourced products, including D.Fill Medium. Verifying original manufacturing certificates and batch-specific lot numbers directly from the supplier is paramount. This diligence applies equally when sourcing other D.Fill variants such as D.Fill Soft or D.Fill Hard, all originating from D.Pharm.

To ensure both regulatory compliance and product integrity, professionals procuring D.Fill Medium should demand comprehensive documentation from their suppliers. This includes, but is not limited to, Certificates of Analysis (CoA) for each specific batch, Certificates of Origin, and valid regulatory approvals relevant to the destination market.

Traceable lot numbers are crucial for post-market surveillance and authenticity verification. A reputable wholesale supplier will readily provide these documents upon request, supporting safe and compliant practice. This level of transparency is a benchmark for professional procurement, as highlighted in comprehensive guides like D.Fill Medium: A Professional Comparison for HA Dermal Fille.

Understanding the commercial aspects is also part of informed sourcing. The illustrative wholesale price for D.Fill Medium is approximately $62.4 per unit. Pricing models typically feature volume-based tiers to benefit larger orders for clinics and resellers. For example, purchasing 11 units might offer a 4% discount, 21 units a 5% discount, 31 units a 6% discount, and orders of 51 units or more could receive an 8% discount.

These structures are designed to support bulk procurement efficiency. When considering comprehensive stock, professionals might also review complementary fillers such as Elasty Plus 1CC for varied treatment indications.